Speyside worked with a leading rare disease company to design a roadmap for market entry, access, and growth in Hungary and the CEE region. Through stakeholder mapping, policy and regulation analysis, and competitive benchmarking, the project delivered clear, actionable recommendations that transformed the client’s commercial strategy, reduced timelines, and significantly increased the likelihood of achieving public market access.

We worked with a leading rare disease company to develop a roadmap for market entry, access and growth in Hungary and across the CEE region.​

Provide a clear understanding of stakeholders, policies and regulation and the route to securing access and reimbursement: who, where, what, when

Desk research supplemented with discrete background discussions with stakeholders and analysis of comparable companies/products.​

Going beyond describing the formal rules of the game to show how it works in practice. Delivery of clear, actionable recommendations.

The client’s commercial strategy and route to market substantially changed as a result of our insights.

Our work has contributed to shorter timelines & significantly higher likelihood of public market access.